SUBSCRIBE
SUBSCRIBE

Carisma Therapeutics

NEWS
Biotech Vets Launch Arrakis With $38 Million and Will be Helmed By Biogen Alum Michael Gilman
Business
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics
June 12, 2017
 · 
2 min read
Load More
AWARDS
  • NextGen Class of 2018
JOBS
IN THE PRESS
Press Releases
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
June 23, 2025
 · 
19 min read
Pharm Country
Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
 · 
1 min read
Drug Development
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
May 16, 2024
 · 
6 min read
Business
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 9, 2024
 · 
14 min read
Drug Development
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024
May 8, 2024
 · 
6 min read
Pharm Country
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences 2024 Conference
May 6, 2024
 · 
1 min read
Business
Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
May 2, 2024
 · 
3 min read
Pharm Country
Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
April 24, 2024
 · 
4 min read
Pharm Country
Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
April 22, 2024
 · 
5 min read
Pharm Country
Carisma Therapeutics to Present at Upcoming April 2024 Conferences
April 3, 2024
 · 
1 min read
Load More